Gaithersburg’s 20/20 GeneSystems, Inc.’s, (“20/20”), Clinical Lab InnovationAxcellerator (CLIAx), received an honorable mention in Fast Company’s 2022 World Changing Ideas Awards in the Health category. The category “honors medical innovations that save lives, extend longevity, or increase access to care.” About 60 companies joined 20/20 as Health category honorees on this year’s coveted Fast Company’s list including Johnson & Johnson, Bose, Abbott, 3M and Colgate-Palmolive.
Believed to be the first shared CLIA lab designed to help diagnostics start-ups more rapidly enter the U.S. market, CLIAx offers nearly 3,000 square feet of ready-to-use communal clinical laboratory space and testing equipment. Additionally, 20/20’s marketing and sales teams help promote the new tests introduced by CLIAx’s clients to the market segments in which 20/20 is currently active. Since its launch in fall 2021, CLIAx was designated by the Maryland Department of Commerce as a “Soft Landing” program for overseas companies seeking to enter the U.S. market, securing its first tenant, Australian-based Minomic International Ltd, a diagnostics firm, with several diagnostics firms coming onboard in the coming months.